Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

被引：0
作者：
Margaret von Mehren
Michael Bookman
Neal J. Meropol
Louis M. Weiner
Eric Sherman
Jinhui Li
Roland Knoblauch
Trilok Parekh
Roger B. Cohen
机构：
[1] Fox Chase Cancer Center,Department of Medical Oncology
[2] US Oncology Research,Arizona Oncology
[3] University Hospitals Case Medical Center,Hematology and Oncology
[4] Seidman Cancer Center,undefined
[5] Georgetown University Medical Center,undefined
[6] Memorial Sloan-Kettering Cancer Center,undefined
[7] Janssen Research & Development,undefined
[8] LLC,undefined
[9] University of Pennsylvania,undefined
[10] Case Comprehensive Cancer Center,undefined
[11] Case Western Reserve University,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Advanced malignancies; Combination chemotherapy; Docetaxel; Ovarian cancer; Sarcoma; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1047 / 1055
页数：8
相关论文
共 50 条
  • [31] A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
    John F. Deeken
    Rebecca Slack
    Glen J. Weiss
    Ramesh K. Ramanathan
    Michael J. Pishvaian
    Jimmy Hwang
    Karen Lewandowski
    Deepa Subramaniam
    Aiwu Ruth He
    Ion Cotarla
    Aquilur Rahman
    John L. Marshall
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 627 - 633
  • [32] Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
    de Jonge, M. J. A.
    Dumez, H.
    Kitzen, J. J. E. M.
    Beuselinck, B.
    Verweij, J.
    Courtney, R.
    Battista, A.
    Brega, N.
    Schoffski, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1328 - 1335
  • [33] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
  • [34] Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
    Schneider, Bryan J.
    Kalemkerian, Gregory P.
    Bradley, Deborah
    Smith, David C.
    Egorin, Merrill J.
    Daignault, Stephanie
    Dunn, Rodney
    Hussain, Maha
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 249 - 257
  • [35] Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
    Bryan J. Schneider
    Gregory P. Kalemkerian
    Deborah Bradley
    David C. Smith
    Merrill J. Egorin
    Stephanie Daignault
    Rodney Dunn
    Maha Hussain
    Investigational New Drugs, 2012, 30 : 249 - 257
  • [36] Phase i study of docetaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Tadao Shimizu
    Kohji Enomoto
    Shunsuke Haga
    Mamoru Fukuda
    Yuichi lino
    Tadashi lkeda
    Tetsuo Taguchi
    Breast Cancer, 2003, 10 (2) : 140 - 148
  • [37] Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
    Wieder, R
    Novick, SC
    Hollis, BW
    Bryan, M
    Chanel, SM
    Owusu, K
    Camastra, D
    Saunders, T
    Pliner, L
    Harrison, J
    Bonate, P
    Williams, T
    Soignet, S
    INVESTIGATIONAL NEW DRUGS, 2003, 21 (04) : 445 - 452
  • [38] Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies
    Mekhail, T
    Hutson, TE
    Elson, P
    Budd, GT
    Srkalovic, G
    Olencki, T
    Peereboom, D
    Pelley, R
    Bukowski, RM
    CANCER, 2003, 97 (01) : 170 - 178
  • [39] Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies
    Robert Wieder
    Steven C. Novick
    Bruce W. Hollis
    Margarette Bryan
    Suzanne M. Chanel
    Kate Owusu
    Danielle Camastra
    Tracie Saunders
    Lillian Pliner
    Jonathan Harrison
    Peter Bonate
    Tom Williams
    Steven Soignet
    Investigational New Drugs, 2003, 21 : 445 - 452
  • [40] Phase I/II study of docetaxel and S-I in patients with advanced gastric cancer
    Yamaguchi, K.
    Shimamura, T.
    Hyodo, I.
    Koizumi, W.
    Doi, T.
    Narahara, H.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    Munakata, M.
    Miyata, Y.
    Maeda, Y.
    Takiuchi, H.
    Nakano, S.
    Esaki, T.
    Kinjo, F.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1803 - 1808
12345